Later this month, members our Healthcare group will be presenting at the HLTH USA 2025 conference in Las Vegas. We have the 8 a.m. session on Tuesday, October 21, 2025, titled “Clinic to Cap Table: IP, Equity, and the Path to Exit,” where we will talk about how to turn clinical insight into a successful company. I am proud to be a part of the panel and will be joined by Kris Kappel, Matt Kamps, and Andrew Landsman. Together, we will share insights on intellectual property, equity, and exit strategies and how these issues intersect in the transactional context.
In the coming week or so, we are going to provide on this blog some introductory thoughts that we will expand upon during our session. This three-part series of blog posts will include:
- Building Companies and Advisory Roles the Right Way: getting the equity stakes right, raising the right kind of capital at the right time, aligning with healthcare regulations, and preparing for diligence are what turn promising insights into sustainable businesses.
- Licensing Software and Intellectual Property: by understanding licensing models, negotiating favorable terms, and integrating IP considerations into business strategy, startups can unlock new opportunities while minimizing legal and operational risks.
- IP Essentials for HLTH—Safeguard and Maximize the Value of Your Life Sciences and MedTech Business: a thoughtful IP posture—right sized to your stage—preserves global rights, smooths diligence, and creates leverage at the negotiating table.
We are excited to present at HLTH USA in Las Vegas and hope to see you there!